Although IFN signature cannot be used as a disease biomarker for SLE4, in our SLE cohort as well in other cross-sectional studies, IFN-High patients tend to have a more severe disease course54, suggesting that ISGs do play a role in the disease pathogenesis. Here, IFNA1 is linked to systemic lupus erythematosus.